In Charity News

 

In 2012 you, our brain tumour community, asked for access to your cancer records, information which before was difficult to access.

By working with you, Cancer Research UK, National Cancer Registration Service (NCRS) and healthcare professionals we have been able to develop a portal that can be used by patients to access and engage with their records.

Why the Patient Portal is important

All of our work aims to put you back in control following a diagnosis.

By being able to access your records you will have more space to compute the information that your clinicians would usually just tell you in person. You’ll be able to fully understand what’s happening at your own pace and, by having this control, you’ll be able to have better and clearer conversations with your clinical team, something you’ve told us is of utmost importance to you.

How the Patient Portal works

You can access your tumour records, held by the NCRS, through a special online portal. Here you’ll be able to engage with:

  • Tissue sample reports
  • Scan reports
  • Data on radio and chemotherapy
  • Information about hospital attendances and treatment
  • Links to treatment options and clinical trials

As we know that a better quality of life often means a better outcome, we’ve also ensured that the portal has a section dedicated to tracking your quality of life during stages of the condition/treatment. And, by integrating quality of life into medical records, we’re making further steps to ensure it’s a priority not just for you, but also health care professionals.

Will Jones, our Director of Development at brainstrust says:

“We know that access to relevant, personalised information is a significant contributing factor to helping people with a brain tumour better understand their situation. This understanding is most important in helping our patients and carers feel less afraid, less isolated and more in control. We are delighted to see the Patient Portal being offered to more people as a result of our expanding collaboration of engaged and committed experts who recognise the significance of information in the battle against cancer. “

Where we are now

The portal has been in development since November 2013, and has been piloted to a number of brain tumour patients across the country, and then extended to other cancer types. The most significant finding of the pilot was that 86% of those who accessed the portal would recommend it to others.

Our plans for the portal were even shortlisted for a Quality in Care Oncology Award in December, and although we didn’t receive the top prize for this work, the project was commended by the judges, with a certificate given to the team on the night.

And just today our Patient Portal poster won first prize at the 2015 NCIN conference.

We’re now currently working on ways to give more patients access to the portal and their records. We’re teaming up with Patients Know Best, in order to integrate NCRS records with this service, so that users can manage all of their medical records in one place.

You can read a more detailed report about the pilot and our next steps on Public Health England’s blog.

 

We hope soon that every patient will be able to access information about the condition that is changing their life. And we hope that by having access, they can feel more prepared and more in control in the face of diagnosis.

 

Click here to access the Patient Portal.

New data released yesterday highlights some of the issues surrounding brain and CNS tumours.Charity News
brainstrust research wins at National Cancer Information Network conferenceCharity News

Introduction

The Brain Tumour Data Dashboard lets you explore up -to-date, population level data about the brain tumours diagnosed in England between 2013 and 2015. Using the drop down menus on the left you can select different groups of patients to view in the charts below. In these charts the number of patients for every 100 diagnoses is displayed as images of people. Patients have been grouped by date of diagnosis, type of tumour, age, gender, and region in England.

For each group of patients you can explore the different routes to diagnosis, the proportion of those who received chemotherapy or radiotherapy, as well as the survival of the patients within each group. For more information about what these metrics mean please see the glossary.

How to use

  1. Select the year of diagnosis using the drop down menu.
  2. Select your patient group of interest from the four drop down menus in the following order:
    1. Tumour group
    2. Age at diagnosis
    3. Region of England
    4. Gender of patient
  3. To view a second chart to compare different groups of patients, click the ‘compare’ button.The second chart will appear below the first chart.

*Note that the tool is best used on a laptop or tablet rather than a mobile phone*

Unavailable data

Some of the data in these charts is not available.There are two main reasons for this:

  1. How the data has been grouped

If you cannot select a patient group from the drop down menus, the data is unavailable because of how the data has been organised.

Public Health England has grouped the data like a branching tree. The bottom of the tree contains all the patients with brain tumours, and then each branch divides the data by a certain characteristics, like age, or location of tumour. But the data is divided in an order, starting with location of the tumour (endocrine or brain), then by age, region, and gender. Age is at the start because it makes a bigger difference to survival rates and treatment rates than gender or region. Sometimes, after the data has been split by type of tumour and age, there is not enough data to be split again. This is because to protect patient confidentiality groups cannot contain less than 100 patients. Because some groups cannot be split further, you cannot create ‘totals’ for everyone by region or gender. For example, you cannot see results for all ages by region, or all brain tumours by gender. If these totals were calculated and released, it might be possible to identify patients, which is why Public Health England cannot release this data.

  1. Statistical reasons and data availability

If you can select a patient group from the chart menus, but the chart does not display, the data is unavailable for one of several reasons:

  1. Data is not yet available for the selected year from Public Health England.
  2. Data is not available because the data quality is too poor to release this statistic.
  3. Data is not available as the statistic is not appropriate for this group.
  4. Data is not available because the standard error of the estimate was greater than 20% and so the estimate has been supressed.

Up to date brain tumour data

Brain tumour data may influence the decisions you make about your care. Data also helps you understand the bigger picture, or landscape, in which you find yourself.

Brain tumour data and statistics influence the focus, and work of organisations like brainstrust. The information helps us to understand the scale and impact of the problems we are setting out to solve.

This tool helps you understand the landscape in which you find yourself having been diagnosed with a brain tumour. This landscape can be particularly tricky to navigate as there are many different types of brain tumour, all of which have a different impact.

The information you see represents the most up-to-date, official, population level brain tumour data available for England. Over time we will be adding to the brain tumour data available and publishing reports, with recommendations, as a result of what we learn from this data.

The data behind this content has come from Public Health England’s National Cancer Registration and Analysis Service (NCRAS) and is a direct result of the ‘Get Data Out’ project.

This project provides anonymised population level brain tumour data for public use in the form of standard output tables, accessible here: http://cancerdata.nhs.uk/standardoutput

Incidence

The number or rate (per head of population) of new cases of a disease diagnosed in a given population during a specified time period (usually a calendar year). The crude rate is the total number of cases divided by the mid-year population, usually expressed per 100,000 population.

Malignant

Malignant tumours which grow by invasion into surrounding tissues and have the ability to metastasise to distant sites

Mortality

The number or rate (per head of population) of deaths in a given population during a specified time period (usually a calendar year). The crude rate is the total number of deaths divided by the mid-year population, usually expressed per 100,000 population.

Non-malignant

Not cancerous. Non-malignant tumours may grow larger but do not spread to other parts of the body.

Survival

The length of time from the date of diagnosis for a disease, such as cancer, that patients diagnosed with the disease are still alive. In a clinical trial, measuring the survival is one way to see how well a new treatment works. Also called ‘overall survival’ or ‘OS’.

Routes to Diagnosis

Under the ‘Routes to Diagnosis’ tab in the Brain Tumour Data Dashboard, you can explore the ways patients have been diagnosed with brain tumours. There are many ways, or routes, for cancers to be diagnosed in the NHS. A ‘route to diagnosis’ is the series of events between a patient and the healthcare system that leads to a diagnosis of cancer. The routes include:

  1. Two Week Wait

Patients are urgently referred by their GP for suspected cancer via the Two Week Wait system and are seen by a specialist within 2 weeks where they are diagnosed.

  1. GP referral

Diagnosis via a GP referral includes routine and urgent referrals where the patient was not referred under the Two Week Wait system.

  1. Emergency Presentation

Cancers can be diagnosed via emergency situations such as via A&E, emergency GP referral, emergency transfer or emergency admission.

  1. Outpatient

Outpatient cancer diagnoses include diagnoses via an elective route which started with an outpatient appointment that is either a self-referral or consultant to consultant referral. (It does not include those under the Two Week Wait referral system).

  1. Inpatient elective

Diagnosis via an inpatient elective route is where diagnosis occurs after the patient has been admitted into secondary care from a waiting list, or where the admission is booked or planned.

  1. Death Certificate Only

Diagnoses made by Death Certificate Only are made where there is no more information about the cancer diagnosis other than the cancer related death notifications. The date of diagnosis is the same as that of the date of death.

  1. Unknown

For some patients with a cancer diagnosis, there is no relevant data available to understand the route to diagnosis.

 

More information

If any of the statistical terms in this section of the brainstrust website are hard to understand, we recommend looking them up here:

Cancer Research UK’s Cancer Statistics Explained

http://www.cancerresearchuk.org/health-professional/cancer-statistics/cancer-stats-explained/statistics-terminology-explained#heading-Seven

If you are looking for help understanding terms relating specifically to brain tumours, and treatment, then the brainstrust glossary is available here:

https://www.brainstrust.org.uk/advice-glossary.php